植物磷胁迫蛋白和铁胁迫蛋白研究进展

综述了近十年来国内外有关研究植物磷胁迫蛋白和铁胁迫蛋白的文献,着重阐述了磷胁迫和铁胁迫条件下的植物蛋白质变化,如新的蛋白和新的多肽的特异产生,以及相关的分子生物学进展。     

植物盐胁迫蛋白

本文概述了植物盐胁迫蛋白(saltstress proteins)的种类、性质、分布和可能的生理意义以及与其他逆境蛋白的联系,并介绍对植物耐盐性分子基础的探索。     

铁胁迫下大豆光合和磷/铁性状对磷素的响应

为了明确低铁胁迫下磷素用量对大豆光合和磷/铁性状的影响及基因型差异,为磷、铁肥的合理施用提供理论依据,以前期筛选的6个磷高效基因型和6个磷低效基因型大豆为供试材料,设4个P∶Fe配比处理,分别为0∶30、30∶30、150 ∶30和300∶30(μmol·L-1),对大豆叶绿素荧光特性和磷、铁利用率进行了测定,利用单株...     

植物低磷胁迫适应机制的研究进展

磷对植物生长发育起到至关重要作用。但是土壤中存在大量植物不可利用的磷。根际周围非常低的有效磷含量是限制植物生长的因素。植物在遭受低磷胁迫时,其根形态、磷酸酶、有机酸、磷转运体等方面会产生一些适应机制。论述了这些机制最新研究进展．并对这一问题的研究方向进行展望。     

植物水分胁迫诱导蛋白的研究进展

主要介绍了植物水分胁迫诱导蛋白的表达模式、特征、分类、功能及其诱导过程中的信号转导及诱导机制。认为胁迫诱导蛋白的产生是植物对逆境胁迫的一种适应性反应,诱导蛋白从多方面保护植物避免或减少胁迫所造成的伤害。植物通过多种途径感受并转导干旱胁迫信号,诱导也多种基因表达产物,从而尽可能地增强对逆境的抗性。     

植物根系形态对低磷胁迫应答的研究进展

本文综述了近年来植物对磷营养高效吸收有关的根系形态方面的研究进展,总结了植物适应低磷胁迫的根系形态特征,以及植物适应低磷胁迫根系形态变化的激素调控的内在机制,着重阐述了植物适应低磷根系形态变化的分子生物学基础,并对开展此类工作的有效途径进行了探讨.     

植物根系形态对低磷胁迫应答的研究进展

本文综述了近年来植物对磷营养高效吸收有关的根系形态方面的研究进展, 总结了植物适应低磷胁迫的根系形态特征, 以及植物适应低磷胁迫根系形态变化的激素调控的内在机制, 着重阐述了植物适应低磷根系形态变化的分子生物学基础, 并对开展此类工作的有效途径进行了探讨。     

植物miRNA介导磷信号转导的研究进展

MicroRNA（miRNA）是一类新型的调控靶基因表达的小分子RNA,参与调节植物的生长发育和抗逆反应等多种生理过程。近年来,随着miR399调节植物磷平衡分子机制的发现,人们开始广泛关注miRNA在低磷信号转导和磷平衡中的作用。本文基于近几年的研究进展,综述miR399、miR827等磷响应miRNA在低磷信号转导以及调节磷平衡过程中的作用和分子生理机制。     

植物锌铁转运蛋白ZIP基因家族的研究进展

金属离子对植物的正常发育至关重要,但过量又会中毒.植物体内的自动调节平衡机制会调节金属离子的吸收和运输,从而控制金属离子的含量.锌铁调控蛋白ZIP( ZRT,IRT-like protein)家族是广泛存在于植物中的转运蛋白,具有Ca2+、Fe2+、Mn2+及Zn2+等多种金属元素的转运功能.了解ZIP转运体在植物中如何发挥离子转运功能,从分子水平认识金属离子缺乏或过量积累的机理有重要意义.综述拟南芥、水稻、大麦、苜蓿和玉米ZIP家族成员及其研究进展.     

磷胁迫对烤烟高亲和磷转运蛋白基因表达及磷素吸收利用的影响

为探明缺磷胁迫对烤烟磷吸收的影响机理,以烤烟品种‘豫烟10号’为材料,采用盆栽试验设置不施磷(-P)和正常供磷(+P)2个处理,分析了烟草生育后期根系和叶片中高亲和磷转运蛋白基因NtPht1;1、NtPht1;2(简称PT1、PT2)的表达差异性及其表达量与烟草磷含量、磷积累量的关系。结果表明:(1)随生育期的推进,烤烟根系和叶片的PT1基因相对表达量、PT2基因相对表达量、干物质重和磷素积累量逐渐增加,烟叶的磷含量逐渐降低,根系磷含量无明显的变化规律。(2)磷胁迫促使PT1、PT2基因的表达量上调,其中叶片PT1基因的相对表达量高于根系,叶片PT2基因的相对表达量显著低于根系。(3)磷胁迫限制了烤烟对干物质和磷素的积累,在移栽后90d,-P处理烤烟根系和叶片的干物质重、磷素积累量不到+P处理的一半,处理间差异极显著。研究认为,在缺磷环境下,烟草高亲和磷转运蛋白基因PT1和PT2表达量的增加,是由磷胁迫下烟草体内磷积累量降低所引起的系统性调控。     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).